REVB
NASDAQ · Biotechnology
Revelation Biosciences Inc
$1.03
-0.02 (-1.90%)
Open$1.03
Previous Close$1.05
Day High$1.07
Day Low$1.03
52W High$39.88
52W Low$0.88
Volume—
Avg Volume80.8K
Market Cap4.03M
P/E Ratio—
EPS$-42.04
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+891.3% upside
Current
$1.03
$1.03
Target
$10.21
$10.21
$7.91
$10.21 avg
$15.75
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 725.2K | 710.5K | 685.3K |
| Net Income | -167,658 | -204,058 | -214,742 |
| Profit Margin | -23.1% | -28.7% | -31.3% |
| EBITDA | -214,609 | -243,655 | -229,479 |
| Free Cash Flow | -113,026 | -111,014 | -146,791 |
| Rev Growth | -8.8% | +0.9% | +1.6% |
| Debt/Equity | 0.76 | 0.62 | 0.70 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |